BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. (BSEM) Stock Price, Quote, News & History

Key Statistics

Open

$4.58

$4.29

Volume / Avg.

82.16K / 61.18K

Day Range

$4.09 - $4.58

52 Wk Range

3.09 - 14.52

Market Cap

P/E Ratio

5.01

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

3.7

Recent Biostem Technologies Inc News

Partner Content

How BioStem Plans To Grow Its Perinatal Allografts In 2023 – And Beyond

Florida-based BioStem Technologies, Inc. (OTCMKTS: BSEM) is a biotech company focused on developing and manufacturing structural-tissue allografts derived from perinatal tissues and intended for use as a protective covering for soft-tissue wounds.

Partner Content

BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research

The below report was authored by Brad Sorensen, CFA, Zacks Small Cap Research. You can find the original report here.

Partner Content

BioStem Technologies, Inc. Second Quarter Financial Results Call, August 22, 2022

C O R P O R A T E P A R T I C I P A N T S Nicolas Johnson, Russo Partners Jason Matuszewski, Chief Executive Officer Michael Fortunato, Controller C O N F E R E N C E C A L L P A R T I C I P A N T S

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

15.27M

Investing Cash Flow (TTM)

-1.80M

Financing Cash Flow (TTM)

-931.94K

Free Cash Flow (TTM)

12.23M

Capital Expenditure (TTM)

-3.05M

Net Change in Cash (TTM)

12.54M

Valuation Metrics

Enterprise Value

$50.37M

PE Ratio (TTM)

5.01

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.36

PB Ratio (TTM)

1.48

Earnings Yield % (TTM)

19.97%

Earnings Yield % (FWD)

-44.26%

EV / EBITDA (TTM)

3.22

Price / EBITDA (TTM)

6.64

Price / Free Cash Flow (TTM)

8.51

Book Value / Share

$2.97

Company Debt

Total Debt

$3.00M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$1.27M

Total Cash

$27.16M

Debt to Equity

0.07

Issuance of Debt (TTM)

-$1.27M

Repayment of Debt (TTM)

-$1.27M

Key Statistics

Open

$4.58

$4.29

Volume / Avg.

82.16K / 61.18K

Day Range

$4.09 - $4.58

52 Wk Range

3.09 - 14.52

Market Cap

P/E Ratio

5.01

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

3.7

About

Sector

Health Care

Industry

Pharmaceuticals

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manu...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. (BSEM) stock?

You can purchase shares of BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. (OTCID:BSEM) through any online brokerage.

View our list of the best stock brokerages

Who are BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. (BSEM) competitors?

There are no as such competitors for BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc..

What is the forecast, or price target, for BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. (BSEM) stock?

There is no analysis for BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. to provide a consensus price target.

What is the current price for BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. (BSEM)?

The stock price for BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. (OTCID: BSEM) is $4.29 last updated May 19, 2026 at 3:58 PM EDT.

Does BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. (BSEM) pay a dividend?

There are no upcoming dividends for BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc..

When is BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. (OTCID:BSEM) reporting earnings?

BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. does not have any upcoming earnings scheduled.

Is BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. (BSEM) going to split?

There is no upcoming split for BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc..

What sector and industry does BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. (BSEM) operate in?

BIOSTEM TECHNOLOGIES NEW by BioStem Technologies, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCID.